Home | Welcome to Contract Pharma   
Last Updated Saturday, May 25 2013
Print RSS Feed

Breaking News

Related Searches: Industry News •
Celgene To Buy Pharmion

November 19, 2007
Celgene Corp. will acquire Pharmion Corp. for $2.9 billion in a move intended to advance Celgene’s strategy to become a global leader in the hematology/oncology field. The transaction brings together Revlimid, Thalomid and Vidaza, products expe…  Read More »
Avastin Shows Promise in Brain Cancer

November 19, 2007
A Phase II trial of Genentech's Avastin showed that the MAb, administered alone or in combination with irinotecan chemotherapy, demonstrated encouraging six-month progression-free survival (PFS) and objective response rate in patients with relapsed g…  Read More »
FTC Approves Schering-Plough/Organon Deal

November 16, 2007
Schering-Plough has received antitrust clearance from the U.S. Federal Trade Commission (FTC) regarding its acquisition of Organon BioSciences from Akzo Nobel. SP received approval from The European Commission on Oct. 11, 2007. Organon BioScience…  Read More »
Pfizer To Acquire Coley

November 16, 2007
Pfizer has announced that it will spend $164 million to acquire Coley Pharmaceutical Group, a publicly-held biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight ca…  Read More »
Trimeris

November 15, 2007
Trimeris has appointed Martin A. Mattingly, Pharm.D. as chief executive officer. Dr. Mattingly will also join the Company's board of directors. Julian Baker, a member of the company's board of directors, remarked, "The Trimeris Board is extre…  Read More »
GPC Biotech To Restructure

November 15, 2007
GPC Biotech has announced plans to restructure, a process that will include layoffs of approximately 44% of the company’s current active workforce. Both the German and U.S. workforce will be cut. The company is "retaining key personnel nee…  Read More »
Pfizer CentreSource

November 14, 2007
Pfizer CentreSource (PCS) has named Jeff Frazier to vice president, Fine Chemicals, and named Kenneth Ball to Marketing Manager. Mr. Frazier previously served as director, Strategic Initiatives and Business Planning and Mr. Ball served as technical d…  Read More »
Azopharma Adds Two Units

November 14, 2007
Azopharma has added a pair of companies to its Azopharma Product Development Group: ApiCross Drug Delivery Technologies and AvivoClin Clinical Services. Based in Hollywood, FL, ApiCross's technology platforms focus on bioavailability enhancement, cus…  Read More »
Nastech Restructures, Spins Off MDRNA

November 14, 2007
Nastech Pharmaceutical plans to restructure in order to reduce operating expenses. The company will launch a subsidiary, MDRNA, Inc., as an independent, separately financed company, while the main company will concentrate on Phase II clinical and par…  Read More »
VaxGen, Raven To Merge

November 13, 2007
VaxGen Inc. and Raven biotechnologies have agreed to merge. The merger is expected to create a drug development company with a "robust pipeline of monoclonal antibody candidates in oncology, proprietary antibody discovery platforms, biopharmaceu…  Read More »
Catalent 1Q

November 13, 2007
Catalent Pharma Solutions 1Q Revenues: $438 million (+10%) 1Q Loss: $11.3 million ($1.1 million in 1Q06 earnings) Comments: Oral Technologies net revenue grew 9% to $235 million, while Sterile Technologies was up 26% to $71 million, fueled b…  Read More »
Pfizer, Nektar Reach Exubera Settlement

November 13, 2007
Pfizer and Nektar Therapeutics have reached an agreement settling their contractual issues regarding Exubera and Nektar's new inhaled insulin product, which is currently in Phase I. Nektar will receive a one-time payment of $135 million from Pfizer t…  Read More »
Alpha Biologics To Manufacture for Synairgen

November 12, 2007
Synairgen, a company developing novel therapies for asthma and COPD, has selected Alpha Biologics to help with the advancement of its growth factor drug development program. Alpha will develop a scaleable manufacturing process for Synairgen's optimiz…  Read More »
Cephalon Submits Fentora sNDA

November 12, 2007
Cephalon has submitted an sNDA to the FDA to market Fentora for the management of breakthrough pain in opioid tolerant patients with chronic pain conditions. Breakthrough pain is characterized by its rapid onset, moderate-to-severe intensity, and rel…  Read More »
Advion Enhances Services

November 12, 2007
Advion BioServices, the bioanalytical services division of Advion BioSciences, Inc., will expand its capacity with the recent acquisition of two Applied Biosystems/MDS Sciex API 5000 mass spectrometers and Waters Acquity UPLC capability. In addition,…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: